These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. Chouinard G. J Clin Psychiatry; 2004; 65 Suppl 5():7-12. PubMed ID: 15078112 [Abstract] [Full Text] [Related]
8. Hypnosedative use and predictors of successful withdrawal in new patients attending a falls clinic: a retrospective, cohort study. Joester J, Vogler CM, Chang K, Hilmer SN. Drugs Aging; 2010 Nov 01; 27(11):915-24. PubMed ID: 20964465 [Abstract] [Full Text] [Related]
14. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam). Saletu B, Anderer P, Brandstätter N, Frey R, Grünberger J, Klösch G, Mandl M, Wetter T, Zeitlhofer J. Neuropsychobiology; 1994 Nov 01; 29(2):69-90. PubMed ID: 8170529 [Abstract] [Full Text] [Related]
16. [Remote consequences of the long-term uncontrollable consumption of anxiolytics and hypnotics in elderly: a problem of drug dependence]. Ivanets NN, Kinkulkina MA, Avdeeva TI, Tikhonova YG. Zh Nevrol Psikhiatr Im S S Korsakova; 2015 Nov 01; 115(7):47-59. PubMed ID: 26356515 [Abstract] [Full Text] [Related]
17. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. Uhlenhuth EH, Balter MB, Ban TA, Yang K. J Clin Psychopharmacol; 1999 Dec 01; 19(6 Suppl 2):23S-29S. PubMed ID: 10587281 [Abstract] [Full Text] [Related]